Michael Mano Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Michael Mano is SVP, General Counsel&Secretary of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 65,075 shares of KPTI, which is worth approximately $363,118. The most recent transaction as insider was on Oct 15, 2025, when has been sold 43,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.1K

209.19% 3M change

76.24% 12M change

Total Value Held $363,118

Michael Mano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	BUY Grant, award, or other acquisition	-	43,650 Added 40.15%	65,075 Common Stock
Sep 15 2025	SELL Open market or private sale	$1,504 $6.43 p/Share	234 Reduced 1.08%	21,425 Common Stock
Sep 12 2025	BUY Grant, award, or other acquisition	-	612 Added 2.75%	21,659 Common Stock
Mar 04 2025	SELL Open market or private sale	$17,567 $6.29 p/Share	2,793 Reduced 11.72%	21,047 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	5,583 Added 18.97%	23,840 Common Stock
Sep 04 2024	SELL Open market or private sale	$2,859 $0.72 p/Share	3,971 Reduced 1.43%	273,881 Common Stock
Mar 01 2024	SELL Open market or private sale	$4,291 $1.2 p/Share	3,576 Reduced 1.27%	277,852 Common
Feb 29 2024	SELL Open market or private sale	$19,858 $1.17 p/Share	16,973 Reduced 5.69%	281,428 Common
Feb 28 2024	BUY Grant, award, or other acquisition	-	147,000 Added 33.0%	298,401 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	9,167 Added 5.71%	151,401 Common Stock
Sep 01 2023	SELL Open market or private sale	$5,171 $1.33 p/Share	3,888 Reduced 2.66%	142,234 Common Stock
Mar 01 2023	SELL Open market or private sale	$20,840 $3.03 p/Share	6,878 Reduced 4.5%	146,122 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	70,000 Added 31.39%	153,000 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	20,000 Added 19.42%	83,000 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	63,000 Added 50.0%	63,000 Common Stock

Michael Mano

SVP, General Counsel&Secretary

Newton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Value

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI

Account